These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 19688967)
1. Clinical relevance of sentinel lymph node status examined with conventional histology and molecular biology. Micciolo R; Boi S; Paoli L; Cristofolini P; Girlando S; Dalla Palma P; Cristofolini M Tumori; 2009; 95(3):298-302. PubMed ID: 19688967 [TBL] [Abstract][Full Text] [Related]
2. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma. Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666 [TBL] [Abstract][Full Text] [Related]
3. Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence. Tatlidil C; Parkhill WS; Giacomantonio CA; Greer WL; Morris SF; Walsh NM Mod Pathol; 2007 Apr; 20(4):427-34. PubMed ID: 17334354 [TBL] [Abstract][Full Text] [Related]
4. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies. Gutzmer R; Kaspari M; Brodersen JP; Mommert S; Völker B; Kapp A; Werfel T; Kiehl P Histopathology; 2002 Dec; 41(6):510-8. PubMed ID: 12460203 [TBL] [Abstract][Full Text] [Related]
5. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma. Blaheta HJ; Schittek B; Breuninger H; Garbe C Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients. Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751 [TBL] [Abstract][Full Text] [Related]
7. Lymphatic mapping and sentinel lymph node biopsy in the management of primary cutaneous melanoma: report of a single-centre experience. Cecchi R; De Gaudio C; Buralli L; Innocenti S Tumori; 2006; 92(2):113-7. PubMed ID: 16724689 [TBL] [Abstract][Full Text] [Related]
8. Sentinel node in melanoma patients: triple negativity with routine techniques and PCR as positive prognostic factor for survival. Denninghoff VC; Falco J; Kahn AG; Trouchot V; Curutchet HP; Elsner B Mod Pathol; 2008 Apr; 21(4):438-44. PubMed ID: 18223554 [TBL] [Abstract][Full Text] [Related]
9. Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma. Ito T; Wada M; Nagae K; Nakano-Nakamura M; Nakahara T; Hagihara A; Furue M; Uchi H J Eur Acad Dermatol Venereol; 2015 May; 29(5):912-8. PubMed ID: 25199412 [TBL] [Abstract][Full Text] [Related]
10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606 [TBL] [Abstract][Full Text] [Related]
11. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden. Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422 [TBL] [Abstract][Full Text] [Related]
12. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306 [TBL] [Abstract][Full Text] [Related]
13. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases]. Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417 [TBL] [Abstract][Full Text] [Related]
14. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966 [TBL] [Abstract][Full Text] [Related]
15. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma. Hochberg M; Lotem M; Gimon Z; Shiloni E; Enk CD Br J Dermatol; 2002 Feb; 146(2):244-9. PubMed ID: 11903234 [TBL] [Abstract][Full Text] [Related]